{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T22:20:03Z","timestamp":1785363603032,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,12]]},"DOI":"10.7759\/cureus.62265","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:39:11Z","timestamp":1718239151000},"source":"Crossref","is-referenced-by-count":4,"title":["Uses of Fecal Microbiota Transplantation in Neurodegenerative Disease: A Scoping Review"],"prefix":"10.7759","author":[{"given":"Jenna","family":"Sanzone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mason","family":"Life","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devan","family":"Reiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianna","family":"Hartley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Spiddle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Al-Kirwi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tigran","family":"Grigoryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Costin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1124234","article-title":"Metagenomic analysis of the human distal gut microbiome","volume":"312","author":"Gill SR","year":"2006","unstructured":"Gill SR, Pop M, Deboy RT, et al.. Metagenomic analysis of the human distal gut microbiome. Science. 2006, 312:1355-9. 10.1126\/science.1124234","journal-title":"Science"},{"key":"ref2","article-title":"The gut microbiome","volume":"46","author":"Sidhu M","year":"2017","unstructured":"Sidhu M, van der Poorten D. The gut microbiome. Aust Fam Physician. 2017, 46:206-11.","journal-title":"Aust Fam Physician"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-017-1175-y","article-title":"Influence of diet on the gut microbiome and implications for human health","volume":"15","author":"Singh RK","year":"2017","unstructured":"Singh RK, Chang HW, Yan D, et al.. Influence of diet on the gut microbiome and implications for human health. J Transl Med. 2017, 15:73. 10.1186\/s12967-017-1175-y","journal-title":"J Transl Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2018.05.008","article-title":"Connecting the immune system, systemic chronic inflammation and the gut microbiome: the role of sex","volume":"92","author":"Rizzetto L","year":"2018","unstructured":"Rizzetto L, Fava F, Tuohy KM, Selmi C. Connecting the immune system, systemic chronic inflammation and the gut microbiome: the role of sex. J Autoimmun. 2018, 92:12-34. 10.1016\/j.jaut.2018.05.008","journal-title":"J Autoimmun"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.10.066","article-title":"The microbiota-gut-brain axis: from motility to mood","volume":"160","author":"Margolis KG","year":"2021","unstructured":"Margolis KG, Cryan JF, Mayer EA. The microbiota-gut-brain axis: from motility to mood. Gastroenterology. 2021, 160:1486-501. 10.1053\/j.gastro.2020.10.066","journal-title":"Gastroenterology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.748254","article-title":"Crosstalk between intestinal serotonergic system and pattern recognition receptors on the microbiota-gut-brain axis","volume":"12","author":"Layunta E","year":"2021","unstructured":"Layunta E, Buey B, Mesonero JE, Latorre E. Crosstalk between intestinal serotonergic system and pattern recognition receptors on the microbiota-gut-brain axis. Front Endocrinol (Lausanne). 2021, 12:748254. 10.3389\/fendo.2021.748254","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2021.105640","article-title":"The gut microbiota-brain axis, psychobiotics and its influence on brain and behaviour: a systematic review","volume":"137","author":"Barrio C","year":"2022","unstructured":"Barrio C, Arias-S\u00e1nchez S, Mart\u00edn-Monz\u00f3n I. The gut microbiota-brain axis, psychobiotics and its influence on brain and behaviour: a systematic review. Psychoneuroendocrinology. 2022, 137:105640. 10.1016\/j.psyneuen.2021.105640","journal-title":"Psychoneuroendocrinology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2174\/157015911796557911","article-title":"Multiple sclerosis: pathogenesis and treatment","volume":"9","author":"Loma I","year":"2011","unstructured":"Loma I, Heyman R. Multiple sclerosis: pathogenesis and treatment. Curr Neuropharmacol. 2011, 9:409-16. 10.2174\/157015911796557911","journal-title":"Curr Neuropharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a029017","article-title":"The gut microbiome and multiple sclerosis","volume":"8","author":"Ochoa-Rep\u00e1raz J","year":"2018","unstructured":"Ochoa-Rep\u00e1raz J, Kirby TO, Kasper LH. The gut microbiome and multiple sclerosis. Cold Spring Harb Perspect Med. 2018, 8:10.1101\/cshperspect.a029017","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"11","author":"Dauer W","year":"2003","unstructured":"Dauer W, Przedborski S. Parkinson's disease: mechanisms and models. Neuron. 2003, 11:889-909. 10.1016\/s0896-6273(03)00568-3","journal-title":"Neuron"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.937555","article-title":"Gut microbiota: a novel therapeutic target for Parkinson's disease","volume":"13","author":"Zhu M","year":"2022","unstructured":"Zhu M, Liu X, Ye Y, et al.. Gut microbiota: a novel therapeutic target for Parkinson's disease. Front Immunol. 2022, 13:937555. 10.3389\/fimmu.2022.937555","journal-title":"Front Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2018.01.022","article-title":"Dementia","volume":"131","author":"Gale SA","year":"2018","unstructured":"Gale SA, Acar D, Daffner KR. Dementia. Am J Med. 2018, 131:1161-9. 10.1016\/j.amjmed.2018.01.022","journal-title":"Am J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2020.110039","article-title":"Gut microbiota in dementia. Critical review of novel findings and their potential application","volume":"104","author":"\u0141uc M","year":"2021","unstructured":"\u0141uc M, Misiak B, Paw\u0142owski M, et al.. Gut microbiota in dementia. Critical review of novel findings and their potential application. Prog Neuropsychopharmacol Biol Psychiatry. 2021, 104:110039. 10.1016\/j.pnpbp.2020.110039","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.7502","article-title":"Factors affecting the composition of the gut microbiota, and its modulation","volume":"7","author":"Hasan N","year":"2019","unstructured":"Hasan N, Yang H. Factors affecting the composition of the gut microbiota, and its modulation. PeerJ. 2019, 7:e7502. 10.7717\/peerj.7502","journal-title":"PeerJ"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.041640","article-title":"Influence of mode of delivery on gut microbiota composition in seven year old children","volume":"53","author":"Salminen S","year":"2004","unstructured":"Salminen S, Gibson GR, McCartney AL, Isolauri E. Influence of mode of delivery on gut microbiota composition in seven year old children. Gut. 2004, 53:1388-9. 10.1136\/gut.2004.041640","journal-title":"Gut"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cobeha.2019.01.011","article-title":"Stress, depression, diet, and the gut microbiota: human-bacteria interactions at the core of psychoneuroimmunology and nutrition","volume":"28","author":"Madison A","year":"2019","unstructured":"Madison A, Kiecolt-Glaser JK. Stress, depression, diet, and the gut microbiota: human-bacteria interactions at the core of psychoneuroimmunology and nutrition. Curr Opin Behav Sci. 2019, 28:105-10. 10.1016\/j.cobeha.2019.01.011","journal-title":"Curr Opin Behav Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-7-101","article-title":"Inhibitory activity spectrum of reuterin produced by Lactobacillus reuteri against intestinal bacteria","volume":"7","author":"Cleusix V","year":"2007","unstructured":"Cleusix V, Lacroix C, Vollenweider S, Duboux M, Le Blay G. Inhibitory activity spectrum of reuterin produced by Lactobacillus reuteri against intestinal bacteria. BMC Microbiol. 2007, 7:101. 10.1186\/1471-2180-7-101","journal-title":"BMC Microbiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-016-0300-5","article-title":"Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials","volume":"8","author":"Kristensen NB","year":"2016","unstructured":"Kristensen NB, Bryrup T, Allin KH, Nielsen T, Hansen TH, Pedersen O. Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials. Genome Med. 2016, 8:52. 10.1186\/s13073-016-0300-5","journal-title":"Genome Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-311915","article-title":"The gut-adherent microbiota of PSC-IBD is distinct to that of IBD","volume":"66","author":"Quraishi MN","year":"2017","unstructured":"Quraishi MN, Sergeant M, Kay G, et al.. The gut-adherent microbiota of PSC-IBD is distinct to that of IBD. Gut. 2017, 66:386-8. 10.1136\/gutjnl-2016-311915","journal-title":"Gut"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/1756283X15607414","article-title":"Fecal microbiota transplantation: in perspective","volume":"9","author":"Gupta S","year":"2016","unstructured":"Gupta S, Allen-Vercoe E, Petrof EO. Fecal microbiota transplantation: in perspective. Therap Adv Gastroenterol. 2016, 9:229-39. 10.1177\/1756283X15607414","journal-title":"Therap Adv Gastroenterol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.172.2.191","article-title":"Fecal transplant via retention enema for refractory or recurrent Clostridium difficile infection","volume":"172","author":"Kassam Z","year":"2012","unstructured":"Kassam Z, Hundal R, Marshall JK, Lee CH. Fecal transplant via retention enema for refractory or recurrent Clostridium difficile infection. Arch Intern Med. 2012, 172:191-3. 10.1001\/archinte.172.2.191","journal-title":"Arch Intern Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccc.2015.11.004","article-title":"The gut as the motor of multiple organ dysfunction in critical illness","volume":"32","author":"Klingensmith NJ","year":"2016","unstructured":"Klingensmith NJ, Coopersmith CM. The gut as the motor of multiple organ dysfunction in critical illness. Crit Care Clin. 2016, 32:203-12. 10.1016\/j.ccc.2015.11.004","journal-title":"Crit Care Clin"},{"key":"ref23","unstructured":"Facts for features. Older Americans month: May 2017. (2017). Accessed: March 8, 2024: https:\/\/www.census.gov\/newsroom\/facts-for-features\/2017\/cb17-ff08.html."},{"key":"ref24","unstructured":"Critical appraisal tools. (2024). Accessed. March 8, 2024: https:\/\/jbi.global\/critical-appraisal-tools."},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3163\/1536-5050.104.3.014","article-title":"De-duplication of database search results for systematic reviews in EndNote","volume":"104","author":"Bramer WM","year":"2016","unstructured":"Bramer WM, Giustini D, de Jonge GB, Holland L, Bekhuis T. De-duplication of database search results for systematic reviews in EndNote. J Med Libr Assoc. 2016, 104:240-3. 10.3163\/1536-5050.104.3.014","journal-title":"J Med Libr Assoc"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00978","article-title":"Single-arm, non-randomized, time series, single-subject study of fecal microbiota transplantation in multiple sclerosis","volume":"11","author":"Engen PA","year":"2020","unstructured":"Engen PA, Zaferiou A, Rasmussen H, et al.. Single-arm, non-randomized, time series, single-subject study of fecal microbiota transplantation in multiple sclerosis. Front Neurol. 2020, 11:978. 10.3389\/fneur.2020.00978","journal-title":"Front Neurol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1177\/20552173221086662","article-title":"Fecal microbiota transplantation is safe and tolerable in patients with multiple sclerosis: a pilot randomized controlled trial","volume":"8","author":"Al KF","year":"2022","unstructured":"Al KF, Craven LJ, Gibbons S, et al.. Fecal microbiota transplantation is safe and tolerable in patients with multiple sclerosis: a pilot randomized controlled trial. Mult Scler J Exp Transl Clin. 2022, 8:20552173221086662. 10.1177\/20552173221086662","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000022035","article-title":"Fecal microbiota transplantation therapy for Parkinson's disease: a preliminary study","volume":"99","author":"Xue LJ","year":"2020","unstructured":"Xue LJ, Yang XZ, Tong Q, et al.. Fecal microbiota transplantation therapy for Parkinson's disease: a preliminary study. Medicine (Baltimore). 2020, 99:e22035. 10.1097\/MD.0000000000022035","journal-title":"Medicine (Baltimore)"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/s12934-021-01589-0","article-title":"Evaluation of fecal microbiota transplantation in Parkinson's disease patients with constipation","volume":"20","author":"Kuai XY","year":"2021","unstructured":"Kuai XY, Yao XH, Xu LJ, et al.. Evaluation of fecal microbiota transplantation in Parkinson's disease patients with constipation. Microb Cell Fact. 2021, 20:98. 10.1186\/s12934-021-01589-0","journal-title":"Microb Cell Fact"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2021.106791","article-title":"Fecal microbiota transplant as a potential treatment for Parkinson's disease - a case series","volume":"207","author":"Segal A","year":"2021","unstructured":"Segal A, Zlotnik Y, Moyal-Atias K, Abuhasira R, Ifergane G. Fecal microbiota transplant as a potential treatment for Parkinson's disease - a case series. Clin Neurol Neurosurg. 2021, 207:106791. 10.1016\/j.clineuro.2021.106791","journal-title":"Clin Neurol Neurosurg"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.18632\/aging.204230","article-title":"Fecal microbiota transplantation can improve cognition in patients with cognitive decline and Clostridioides difficile infection","volume":"14","author":"Park SH","year":"2022","unstructured":"Park SH, Lee JH, Kim JS, et al.. Fecal microbiota transplantation can improve cognition in patients with cognitive decline and Clostridioides difficile infection. Aging (Albany NY). 2022, 14:6449-66. 10.18632\/aging.204230","journal-title":"Aging (Albany NY)"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00098","article-title":"Fecal microbiota transplantation in neurological disorders","volume":"10","author":"Vendrik KE","year":"2020","unstructured":"Vendrik KE, Ooijevaar RE, de Jong PR, et al.. Fecal microbiota transplantation in neurological disorders. Front Cell Infect Microbiol. 2020, 10:98. 10.3389\/fcimb.2020.00098","journal-title":"Front Cell Infect Microbiol"},{"key":"ref34","unstructured":"FDA approves first fecal microbiota product. (2022). Accessed. December 1, 2022: https:\/\/www.biospace.com\/article\/releases\/fda-approves-first-fecal-microbiota-product\/."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/251126-uses-of-fecal-microbiota-transplantation-in-neurodegenerative-disease-a-scoping-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:39:18Z","timestamp":1718239158000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/251126-uses-of-fecal-microbiota-transplantation-in-neurodegenerative-disease-a-scoping-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,12]]},"references-count":34,"URL":"https:\/\/doi.org\/10.7759\/cureus.62265","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,12]]}}}